Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i

Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i

US Patent 9200061 · Granted Dec 1, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific EGFR/CD16 antigen-binding protein2024
Generation and profiling of fully human HuCAL gold-derived therapeutic antibodie2024
Bispecific EGFR/CD16 antigen-binding protein2022
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodie2021
NK cell engaging antibody fusion constructs2021
Nucleic acids encoding anti-Factor P antibodies2020
4-1BB binding molecules2020
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodie2019
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodie2019
Compositions comprising antibodies targeting factor P2018
Anti-staphylococcal antibodies2018
Anti-CD38 human antibodies and uses thereof2017